Trial intelligence / Profile preview

Presurgical phase II study of metformin in breast cancer

2008-004912-10Phase 2Completed

Sponsor
European Institute of Oncology
Start
Nov 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial in breast cancer comparing Metformin with Placebo (2 arms). Primary endpoint: Change in Ki-67 in breast cancer tissue. Started Nov 2008; status: completed.

02

Drugs

metformin
03

Conditions

breast cancer

Beyond the preview

Go deeper on 2008-004912-10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-004912-10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call